Olympus advised providers to stop using an endoscope accessory due to an infection risk linked to 120 injuries and one death.

Officials commissioned the independent review in September in response to a study that found tampons may expose users to ...

Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.

Stefan Kaufmann, former CEO of Tokyo-based Olympus, stepped down in October after the company investigated an allegation that ...

Kolaleh Eskandanian, chief innovation officer at Children’s National Hospital, said the partnership is meant to address the ...

Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead ...

Globus Medical and Thermo Fisher were among the companies to announce billion dollar deals this year, while Medtronic and Boston Scientific called off acquisitions.

Medtech firms have cut thousands of workers in the last two years, leaving employees wondering what’s to come in 2025. A MedTech Dive analysis found that there have been more than 14,000 layoffs ...

The company collaborated with Zimmer Biomet on its Persona IQ device, which is slated for a full market release this year. Canary is also working on an implantable monitor for heart failure patients.

Boston Scientific has updated the instructions for its Polarx and Polarx FIT cryoablation balloon catheters, the Food and Drug Administration said Wednesday. The update followed a higher than expected ...

Dexcom received FDA clearance in March for the first over-the-counter glucose monitor, called Stelo. It’s cleared for adults who don’t take insulin, including people with Type 2 diabetes. The wellness ...

Inspectors found 111 open tickets for software defects categorized as catastrophic or severe patient harm. Several safety complaints were listed that BD didn’t report within the required timeframe.